“At Kinsella Group, our buy-side process begins with gaining a solid understanding of our client’s unique needs. We ask lots of questions and assume nothing. In addition, we find that the discussion around our client’s needs leads to new insights; these insights sometimes take us in directions that our client did not originally consider.”

Curt Jennewine

Managing Director

Curt Jennewine

Curt Jennewine Form

Curt Jennewine is a Medical Device Executive and Board Director with over 25 years of Sales, Marketing and Operational success. Throughout his career Mr. Jennewine and his teams have achieved industry-leading growth at large, medium and small sized companies, including Abbott, Zimmer, Guidant and Acumed. Much of his success has been generated through leadership in strategy, structural realignment, innovative product development, channel optimization and new product launch discipline. Mr. Jennewine has worked with numerous medical technologies, including those in Orthopedics, Trauma, Spine, Vascular Intervention, Cardiac Rhythm Management, Diabetes, in vitro Diagnostics and Infection Prevention among others.

In addition to his accomplishments in the United States, Mr. Jennewine has achieved significant business success internationally as well. He lived and worked for more than 13 years in Asia and Europe, spending significant time in Japan, China, and Germany. He is also fluent in Japanese, conversational in German, and able to speak basic Mandarin. These international experiences imbued Mr. Jennewine with deep curiosity and creative problem-solving skills that have led to him generating over 15 medical device patents and licenses.

Mr. Jennewine’s educational background includes a Master of Management degree from the Kellogg School of Management at Northwestern University and a Bachelor of Arts degree from Duke University. He enjoys spending his free time outdoors in the Pacific Northwest and training for his next triathlon.